Announcement

Collapse
No announcement yet.

Vumerity newly approved

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Vumerity newly approved

    Vumerity™ Oral Capsules Approved by the FDA for Adults with Relapsing Forms of MS, Including Active SPMS https://mymsaa.org/news/vumerity-app...ent=email_body

    Vumerity is in the same class of MS therapy as Biogen’s Tecfidera® (dimethyl fumarate), but is believed to cause fewer gastrointestinal (GI) side effects – such as diarrhea, nausea, vomiting, and abdominal pain. Data covering 48 weeks of treatment showed that relapse rates fell approximately 80% among the entire study group relative to baseline. In addition, the number of gadolinium-enhancing lesions seen on MRI was reduced by 77% from baseline for the entire group and by 96% from baseline for the individuals who were newly diagnosed.”
    1st sx '89 Dx '99 w/RRMS - SP since 2010
    Administrator Message Boards/Moderator

    #2
    vumerity

    Does Vumerity help with fatigue or just helps progression?

    Comment

    Working...
    X